{"database": "openregs", "table": "dockets", "rows": [["FDA-2004-D-0353", "FDA", "Guidance for FDA Review Staff and Sponsors:  Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)", "Nonrulemaking", "2021-09-01T01:02:18Z", "0b00006480473538"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2004-D-0353"], "units": {}, "query_ms": 21.879905951209366, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}